AI Scribe for Rheumatology
Transcribe Health drafts your consult, follow-up, and injection notes while you work, so the joint counts and drug decisions are on the page before you leave the room.
Photo: National Cancer Institute / Unsplash
Rheumatology documentation, from first workup to long-term monitoring
Rheumatology visits carry a lot of moving parts. A single follow-up can touch a joint count, a disease-activity score, three months of CBC and liver enzymes, a biologic dose, and a patient-reported flare, and each one has to land in the note with the actual number and the reason behind it. New consults are heavier still, because you are sorting an undifferentiated presentation against a long list of serologies and organ systems.
The exam alone is dense. Counting tender and swollen joints, grading synovitis, checking enthesitis or dactylitis, then folding that into a DAS28 or CDAI takes real attention, and it is the part that gets compressed when you are charting between patients. Miss it and the note no longer supports the E/M level or the case for staying on an expensive drug.
Transcribe Health listens to the visit, or to your narration after an injection, and drafts a note that keeps the rheumatology detail where it belongs: joint counts, activity scores, drug names and doses, lab surveillance, and the reasoning behind your assessment. You read it and sign. Nothing is filed without you.
Documentation Challenges in Rheumatology
- 1
Recording tender and swollen joint counts across 28 or 66/68 joints, plus the disease-activity score they feed into
- 2
Tracking DMARD and biologic monitoring: lab surveillance, dose changes, TB and hepatitis screening, and the reason behind each step-up or hold
- 3
Working through a multisystem autoimmune presentation where skin, kidney, lung, and serology findings all belong in one note
How Transcribe Health Helps Rheumatology
Joint Exam and Activity Scores
Captures the tender and swollen joint counts you call out and records the DAS28 or CDAI you calculated, with the values that went into it.
DMARD and Biologic Monitoring
Records the methotrexate, adalimumab, or rituximab plan, the lab results you reviewed, and the reason for a dose change or hold.
Multisystem Workup Notes
Puts the serology, imaging, and organ-system findings you dictate into one structured note when you are working up lupus, vasculitis, or an undifferentiated connective tissue disease.
A rheumatology note, captured in real time
An abridged follow-up for a rheumatoid arthritis patient on a biologic, drafted the way you would see it before signing.
54-year-old woman with seropositive rheumatoid arthritis, seen for routine follow-up. Reports about 30 minutes of morning stiffness, down from over an hour at her last visit. Occasional soreness in the right wrist and left MCPs but no new joint swelling. On methotrexate 20 mg weekly with folic acid and adalimumab 40 mg every two weeks, both tolerated well. No cough, fever, or recent infections. Denies mouth ulcers, rash, or new shortness of breath.
Tender joint count 3 (right wrist, left second and third MCPs). Swollen joint count 1 (left second MCP). No effusions at the knees, no enthesitis. Skin clear, no nodules. Labs today: ESR 18 mm/hr, CRP 6 mg/L, CBC and comprehensive metabolic panel within normal limits, AST and ALT normal. DAS28-CRP 2.9.
1) Seropositive rheumatoid arthritis, low disease activity by DAS28-CRP, improved from moderate activity at prior visit. 2) On combination methotrexate and adalimumab, tolerating both with no lab abnormalities. 3) No signs of infection or drug toxicity today.
Continue methotrexate 20 mg weekly with folic acid 1 mg daily and adalimumab 40 mg subcutaneously every two weeks. Recheck CBC, AST, ALT, and creatinine in 8 weeks per methotrexate monitoring. Continue vitamin D. Counseled on holding methotrexate during any significant infection. Return in 3 months, sooner if she has a flare. Repeat DAS28 at next visit to confirm she stays in target.
Illustrative example. Not a real patient encounter.
Built for rheumatology coding and your EMR
Notes capture the joint counts, activity scores, labs you reviewed, and the drug-related risk that back up your E/M level and an injection's medical necessity. That is the detail auditors look for, and the first thing to slip when charting is rushed.
- 99204 / 99205New-patient consult, moderate to high complexity
- 99214 / 99215Established-patient follow-up, moderate to high complexity
- 20610Arthrocentesis or injection, major joint or bursa (knee, shoulder, hip)
- 20605Arthrocentesis or injection, intermediate joint or bursa (wrist, elbow, ankle)
- 96401Chemotherapy or non-hormonal injection, subcutaneous or intramuscular (rituximab)
- 96413Chemotherapy or complex drug infusion, up to one hour, single agent
- M05.79Rheumatoid arthritis with rheumatoid factor, multiple sites, without organ involvement
- M06.9Rheumatoid arthritis, unspecified
- M32.9Systemic lupus erythematosus, unspecified
- M10.9Gout, unspecified
- M45.9Ankylosing spondylitis of unspecified sites in spine
Fits the workflow you already have
Drafts drop into the major EMRs rheumatology groups run on: Epic, Oracle Health (Cerner), and athenahealth. You get whatever note type you are working in, a new consult, a follow-up, or an injection report. It writes up the joint counts, activity scores, and lab review you dictate. It does not read your imaging or pull results from your lab interface for you; you make the call and it records it.
Rheumatology AI scribe questions
Does it understand rheumatology terminology and drug names?
Can it record joint counts and activity scores?
Does it document injections and infusions, or only office visits?
How is patient information protected?
Does it connect to our EMR and lab systems?
Ready to Transform Your Documentation?
Join thousands of healthcare providers who save hours every day with AI-powered medical transcription.
Start Free Trial